These results strongly indicate that reduced TRIM21 expression is probably a cause, not a consequence, of obesity-associated metabolic disorder, which was further supported by the hepatic TRIM21 knockdown experiment in mice, which promoted liver steatosis and insulin resistance. This evidence concerns the gene TRIM21 and fatty liver disease.